STOCK TITAN

Tango Therapeutics to Present at the Jefferies London Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Tango Therapeutics, Inc. (NASDAQ: TNGX) will have its President and CEO, Barbara Weber, M.D., present at the Jefferies London Healthcare Conference on November 14, 2023, at 1:00 PM GMT. The presentation will be available via live webcast and will be archived on the company's website for 90 days.
Positive
  • None.
Negative
  • None.

BOSTON, Nov. 07, 2023 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (NASDAQ: TNGX), a clinical-stage biotechnology company committed to discovering and delivering the next generation of precision cancer medicines, today announced that Barbara Weber, M.D., President and Chief Executive Officer of Tango Therapeutics, is scheduled to present at the Jefferies London Healthcare Conference on Tuesday, November 14, 2023 at 1:00 PM GMT.

A live webcast of the presentation will be available under the "Events & Presentations" tab on the “Investors” page on the Company's website on the day of the event. A replay of the webcast will be archived on the Company's website for 90 days following the presentation.

About Tango Therapeutics

Tango Therapeutics is a clinical-stage biotechnology company dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. Using an approach that starts and ends with patients, Tango leverages the genetic principle of synthetic lethality to discover and develop therapies that take aim at critical targets in cancer. This includes expanding the universe of precision oncology targets into novel areas such as tumor suppressor gene loss and their contribution to the ability of cancer cells to evade immune cell killing. For more information, please visit www.tangotx.com.

Investor Contact:
Sam Martin/Andrew Vulis
Argot Partners
tango@argotpartners.com

Media Contact:
Amanda Galgay
SVP, Corporate Communications, Tango Therapeutics
media@tangotx.com


FAQ

What is the date of the Jefferies London Healthcare Conference presentation for Tango Therapeutics, Inc. (NASDAQ: TNGX)?

The presentation is scheduled for November 14, 2023.

Who will be presenting at the conference for Tango Therapeutics, Inc. (NASDAQ: TNGX)?

Barbara Weber, M.D., the President and Chief Executive Officer of Tango Therapeutics, will be presenting.

Where can I watch the presentation of Tango Therapeutics, Inc. (NASDAQ: TNGX)?

The presentation will be available via live webcast on the company's website under the 'Events & Presentations' tab on the 'Investors' page.

How long will the webcast of the presentation be available for viewing on the company's website for Tango Therapeutics, Inc. (NASDAQ: TNGX)?

The webcast will be archived on the company's website for 90 days following the presentation.

Tango Therapeutics, Inc.

NASDAQ:TNGX

TNGX Rankings

TNGX Latest News

TNGX Stock Data

812.26M
46.25M
13.51%
88.51%
9.55%
Pharmaceutical Preparation Manufacturing
Manufacturing
Link
United States of America
BOSTON

About TNGX

tango therapeutics is a biotechnology company discovering and developing novel medicines targeting cancer vulnerabilities to deliver transformational new therapies for patients. tango was launched in 2017 with a $55 million series a investment from third rock ventures. the company has established a robust product engine that leverages advances in dna sequencing and crispr-based target discovery to generate breakthrough medicines that have the potential to provide deeper, more sustained benefit than today’s targeted therapies, and extend the benefit of available immuno-oncology agents. tango therapeutics is focused on three areas of drug development, each in well-defined patient populations currently lacking effective treatment options, and each with hallmarks of cancer that have not been targeted yet. these include: loss of tumor suppressor gene function; multiple oncogenic drivers; and immune evasion. what fuels each of tango’s programs is an increasingly sophisticated ability to util